period
patient
manag
two
parisian
referr
center
possibl
merscov
infect
none
confirm
merscov
posit
season
influenza
virus
common
pathogen
bacteri
pneumonia
also
diagnos
middl
east
respiratori
syndrom
coronaviru
merscov
singlestrand
positivesens
rna
viru
firstli
isol
kingdom
saudi
arabia
ksa
decemb
world
health
organ
report
laboratoryconfirm
case
merscov
death
differ
countri
merscov
zoonot
viru
incomplet
elucid
origin
dromedari
camel
suspect
reservoir
bat
possibl
origin
harbor
relat
viral
sequenc
humantohuman
transmiss
requir
close
contact
infect
peopl
date
report
merscov
case
occur
individu
arabian
peninsula
countri
travel
return
area
trace
ill
travel
year
muslim
hajj
umrah
pilgrimag
million
peopl
travel
middl
east
period
high
risk
among
pilgrim
acquisit
respiratori
tract
infect
includ
merscov
although
risk
merscov
acquisit
extrem
low
pilgrim
travel
consequ
acquisit
dread
illustr
south
korean
outbreak
one
index
case
led
secondari
tertiari
case
includ
death
nosocomi
epidem
event
also
describ
ksa
new
case
resid
still
report
monthli
report
show
merscov
mostli
character
nosocomi
transmiss
famili
cluster
interestingli
shown
crosstransmiss
contain
home
well
hospit
set
suspect
case
put
contact
restrict
enhanc
hygien
procedur
appli
combin
rapid
test
merscov
franc
nation
plan
set
refer
ward
identifi
region
rapid
isol
suspect
case
prompt
case
ascertain
base
epidemiolog
clinic
characterist
help
nation
institut
health
despit
framework
one
case
merscov
infect
identifi
travel
middl
east
region
led
secondari
case
nosocomi
acquisit
clinic
symptom
merscov
infect
low
specif
therefor
true
etiolog
acut
respiratori
syndrom
overlook
focus
merscov
infect
suspect
case
may
result
lost
opportun
particularli
true
period
peopl
return
hajj
number
suspect
case
increas
greatli
short
time
report
fouryear
experi
pari
area
manag
outcom
patient
hospit
two
isol
ward
suspect
merscov
infect
perform
descript
analysi
better
defin
virus
bacteria
caus
infect
merscov
neg
popul
retrospect
analysi
carri
infecti
diseas
depart
two
univers
hospit
bichat
claud
bernard
pari
franc
depart
part
parisil
de
franc
region
plan
manag
contagi
emerg
infecti
diseas
adult
serv
referr
center
emerg
infecti
diseas
pari
area
isol
ward
dedic
room
anteroom
neg
pressur
enrol
patient
admit
two
ward
classifi
possibl
case
merscov
infect
defin
epidemiolog
bulletin
hospit
patient
epidemiolog
data
collect
demograph
characterist
travel
histori
purpos
travel
contact
anim
sick
peopl
inpati
outpati
visit
travel
also
record
natur
initi
symptom
lag
time
symptom
onset
date
departur
atrisk
region
hospit
isol
ward
upon
admiss
isol
ward
clinic
symptom
comorbid
studi
initi
laboratori
find
assess
chest
xray
defin
normal
show
alveolar
interstiti
infiltr
clinic
manag
evalu
term
place
hospit
antibiot
treatment
antivir
use
oxygen
administr
microbiolog
paramet
record
includ
bacteriolog
virolog
test
perform
hospit
stay
patient
nasopharyng
specimen
collect
realtim
rtpcr
analysi
respiratori
specimen
obtain
soon
possibl
cours
ill
within
day
symptom
onset
laboratori
confirm
merscov
infect
perform
site
sinc
open
hour
local
laboratori
pasteur
institut
refer
laboratori
night
weekend
confirm
perform
specif
realtim
rtpcr
assay
use
two
differ
merscov
genom
target
site
region
upstream
envelop
gene
site
film
array
rapid
multiplex
pcr
perform
simultan
qualit
detect
identif
multipl
respiratori
viral
bacteri
nucleic
acid
nasopharyng
swab
respiratori
panel
lyon
franc
adenoviru
coronavirus
human
metapneumoviru
influenza
b
virus
parainfluenza
virus
respiratori
b
virus
bordetella
pertussi
chlamydophila
pneumonia
mycoplasma
pneumonia
bacteria
document
use
divers
method
includ
blood
cultur
serolog
urinari
antigen
sputum
pulmonari
sampl
respect
blood
smear
malaria
perform
atrisk
travel
isol
maintain
neg
result
obtain
merscov
symptom
day
old
otherwis
second
sampl
need
durat
isol
total
durat
hospit
record
comparison
perform
use
kruskalw
test
continu
variabl
pearson
fisher
exact
test
categor
variabl
statist
analysi
perform
use
r
vienna
austria
signific
set
pvalu
accord
french
health
public
law
csp
art
investig
requir
specif
inform
consent
ethic
committe
approv
retrospect
studi
without
medic
intervent
januari
decemb
adult
patient
classifi
possibl
merscov
case
hospit
two
particip
isol
ward
male
femal
ratio
median
age
year
interquartil
rang
iqr
patient
return
ksa
travel
pilgrimag
two
profession
reason
four
tourism
two
ksa
resid
fig
obviou
season
trend
major
annual
increas
number
admit
patient
annual
hajj
period
fig
median
travel
durat
day
iqr
median
lag
time
first
symptom
admiss
isol
ward
day
iqr
median
lag
time
arriv
franc
admiss
isol
ward
day
iqr
day
patient
first
symptom
arriv
franc
first
symptom
describ
patient
cough
n
influenzalik
symptom
n
dyspnea
n
symptom
diarrhea
n
fever
n
vomit
n
gener
ill
n
headach
thirtyfour
patient
consult
physician
atrisk
countri
nine
prior
hospit
countri
close
contact
ill
travel
respiratori
symptom
travel
found
patient
exposur
dromedari
camel
contamin
camel
milk
meat
found
five
patient
initi
clinic
find
patient
admit
isol
ward
report
tabl
common
sign
cough
patient
sputum
product
dri
cough
pulmonari
auscult
reveal
crackl
patient
bilater
ten
patient
requir
oxygen
therapi
initi
evalu
clinic
symptom
list
tabl
ten
patient
admit
intens
care
directli
n
evalu
isol
ward
n
seventyf
patient
underli
medic
condit
median
differ
comorbid
hypertens
n
chronic
respiratori
diseas
n
chronic
cardiac
diseas
n
obes
n
nine
patient
histori
neoplast
hematolog
diseas
six
receiv
corticosteroid
six
immunosuppress
drug
initi
chest
xray
avail
patient
find
abnorm
thirtynin
exhibit
alveolar
opac
bilater
local
interstiti
syndrom
includ
bilater
local
alveolar
interstiti
syndrom
bilater
local
addit
file
figur
laboratori
find
report
tabl
admiss
median
creactiv
protein
mgdl
mgdl
patient
neutrophil
count
increas
patient
median
neutrophil
count
gl
among
patient
initi
receiv
antibiot
therapi
antibiot
combin
ac
singl
antibiot
ac
administ
median
durat
h
iqr
secondarili
switch
case
discontinu
ac
thirdgener
cephalosporin
macrolid
patient
aminopenicillin
macrolid
three
patient
thirdgener
cephalosporin
fluoroquinolon
four
patient
ac
maintain
case
six
quinolon
plu
spyramicin
rifampicin
four
thirtyeight
patient
switch
singl
antibiot
amoxicillinclavulan
thirdgener
cephalosporin
eight
amoxicillin
seven
spiramycin
six
levofloxacin
three
piperacillintazobactam
doxycyclin
one
singl
antibiot
initi
prescrib
amoxicillinclavulan
nine
patient
amoxicillin
five
thirdgener
cephalosporin
four
antibiot
maintain
throughout
treatment
case
switch
oral
amoxicillinclavulan
four
case
discontinu
first
hour
treatment
oseltamivir
given
patient
median
durat
h
discontinu
h
patient
h
day
patient
kept
entir
treatment
durat
patient
oxygen
therapi
requir
patient
median
maxim
flow
lmin
iqr
five
patient
oxygen
flow
lmin
transfer
intens
care
none
patient
hospit
suspect
merscov
inhibit
found
posit
merscov
pcr
microbiolog
etiolog
identifi
patient
tabl
viral
infect
document
patient
includ
human
rhinoviru
hrv
influenza
viru
latter
type
viru
identifi
approxim
half
case
bacteri
infect
document
patient
common
etiolog
legionella
pneumophila
streptococcu
pneumonia
patient
patient
legionnair
diseas
ld
chronic
cardiac
diseas
immunosuppress
patient
data
shown
final
ld
longer
durat
hospit
manag
day
vs
day
p
plasmodium
falciparum
malaria
diagnos
mix
infect
document
patient
mix
viral
infect
mix
virusbacteri
infect
empir
antibiot
therapi
prescrib
patient
document
bacteri
infect
effect
bacteri
strain
secondarili
document
cours
diseas
among
patient
document
viral
infect
receiv
empir
antibiot
therapi
lastli
patient
without
document
receiv
empir
antibiot
therapi
patient
document
influenza
viru
receiv
neuraminidas
inhibitor
oseltamivir
durat
isol
calcul
initi
confin
trigger
suspicion
merscov
infect
upon
remov
order
physician
follow
receipt
neg
result
merscov
analysi
median
durat
isol
precaut
h
iqr
rang
h
durat
isol
decreas
significantli
year
median
h
h
p
fig
patient
hospit
isol
ward
median
three
day
iqr
total
manag
durat
alert
hospit
discharg
four
day
iqr
two
patient
die
malign
flu
staphylococcu
aureu
relat
prosthet
heart
valv
infect
endocard
respect
fouryear
period
includ
four
hajj
umrah
pilgrimag
two
center
manag
patient
possibl
merscov
infect
none
patient
return
endem
countri
classifi
possibl
case
confirm
merscov
posit
season
virus
influenza
virus
common
pathogen
identifi
lifethreaten
bacteri
pneumonia
also
diagnos
influenza
virus
found
microbiolog
document
patient
consist
result
show
preval
rang
patient
suspect
merscov
infect
iranian
studi
influenza
preval
around
pilgrim
upper
respiratori
tract
infect
result
suggest
empir
oseltamivir
therapi
initi
patient
admit
isol
ward
suspect
merscov
infect
antivir
treatment
discontinu
pcr
result
prove
neg
influenza
moreov
result
illustr
import
prevent
flu
vaccin
prior
pilgrimag
travel
area
merscov
endem
studi
patient
posit
hrv
compar
two
studi
also
agreement
studi
french
pilgrim
demonstr
acquisit
hrv
trip
use
pre
posttravel
routin
screen
hrv
involv
acut
respiratori
infect
remain
controversi
studi
phylogenet
epidemiolog
characterist
necessari
clarifi
clinic
impact
viru
altogeth
onequart
patient
speci
infect
associ
viral
infect
two
frequent
document
bacteria
pneumonia
l
pneumophila
pneumococc
diseas
diagnos
seven
patient
receiv
empir
antibiot
effect
pneumonia
show
pneumonia
carriag
increas
french
pilgrim
hajj
wherea
vaccin
coverag
low
french
hajj
pilgrim
therefor
pneumococc
vaccin
propos
atrisk
person
hajj
pilgrimag
seven
patient
present
l
pneumophila
infect
previou
underli
condit
greater
chronic
cardiac
diseas
immunosuppress
statu
initi
evalu
present
headach
increas
respiratori
frequenc
intens
dyspnea
prolong
durat
hospit
none
die
two
patient
requir
admiss
intens
care
unit
ld
alreadi
report
altern
diagnosi
merscov
infect
seri
suspect
patient
posit
result
altern
respiratori
pathogen
includ
two
ld
pilgrim
hajj
frequent
stay
accommod
open
pilgrimag
legionella
spp
caus
bacterium
found
natur
fresh
water
contamin
hot
tub
cool
tower
air
condition
condit
accommod
could
partli
explain
ld
acquisit
travel
recent
report
european
centr
diseas
prevent
control
laboratoryconfirm
case
ld
diagnos
travel
european
union
dubai
sinc
octob
repres
signific
increas
averag
incid
probabl
ld
patient
possibl
merscov
infect
highlight
need
initi
antibiot
combin
antilegionella
efficaci
local
surveil
pilgrim
facil
one
patient
p
falciparum
infect
patient
made
stopov
mali
without
antimalari
chemoprophylaxi
return
trip
franc
antimalari
treatment
propos
everi
patient
suspect
merscov
infect
come
back
malari
endem
region
sporad
travelassoci
merscov
case
report
outsid
arabian
peninsula
differ
countri
involv
includ
republ
south
korea
rsk
regard
high
number
travel
stay
atrisk
countri
especi
hajj
merscov
transmiss
remain
rare
recent
merscov
surveil
studi
conduct
ksa
annual
hajj
pilgrimag
peopl
screen
septemb
none
test
posit
merscov
also
support
absenc
persontoperson
merscov
transmiss
mass
gather
hajj
nosocomi
transmiss
merscov
ksa
rsk
could
contain
everi
suspect
case
manag
strict
isol
precaut
organ
implement
franc
alert
system
referr
depart
train
organ
receiv
possibl
infect
patient
organ
requir
transfer
patient
first
care
facil
suspicion
aris
referr
isol
ward
might
delay
appropri
manag
patient
acut
respiratori
infect
result
lost
opportun
alreadi
detail
one
two
case
studi
period
patient
possibl
merscov
infect
mostli
admit
short
time
period
link
pilgrimag
period
fig
moreov
low
specif
clinic
symptom
could
lead
medic
mistak
lifethreaten
diseas
fulli
cover
empir
antimicrobi
treatment
laboratori
test
limit
set
exclud
blood
cultur
studi
four
diagnos
like
delay
cover
empir
treatment
prescrib
q
fever
malaria
aureu
endocard
stomat
studi
limit
retrospect
data
could
obtain
patient
two
merscov
document
case
north
franc
sinc
two
case
new
case
describ
everi
year
thousand
pilgrim
travel
return
endem
countri
respiratori
syndrom
engag
merscov
procedur
lead
transfer
patient
isol
ward
diagnosi
exclus
take
control
group
french
nontravel
patient
hospit
respiratori
infect
seem
inappropri
similar
way
use
travel
hospit
respiratori
tract
infect
seem
relev
differ
would
travel
destin
shown
travel
pandem
knowledg
merscov
grown
year
time
manag
possibl
case
improv
term
empir
treatment
could
influenc
result
merscov
rtpcr
made
avail
local
thu
reduc
time
diagnosi
also
influenc
time
day
patient
arriv
link
local
laboratori
open
hour
empir
antivir
treatment
neuraminidas
inhibitor
well
antibiot
treatment
effect
infect
due
l
pneumophila
pneumonia
consid
patient
suspect
merscov
infect
altogeth
result
argu
specif
infecti
diseas
unit
dedic
emerg
infecti
diseas
manag
also
develop
new
tool
simplifi
expedit
diagnost
process
patient
suspect
merscov
infect
order
interrupt
isol
procedur
earlier
